176 related articles for article (PubMed ID: 27998701)
21. Association between anti-Mullerian hormone and insulin resistance in non-obese adolescent females with polycystic ovary syndrome.
Tokmak A; Kokanali D; Timur H; Kuntay Kokanali M; Yilmaz N
Gynecol Endocrinol; 2016 Nov; 32(11):926-930. PubMed ID: 27275748
[TBL] [Abstract][Full Text] [Related]
22. Threshold value of anti-Mullerian hormone for the diagnosis of polycystic ovary syndrome in Chinese women.
Yue CY; Lu LK; Li M; Zhang QL; Ying CM
PLoS One; 2018; 13(8):e0203129. PubMed ID: 30153296
[TBL] [Abstract][Full Text] [Related]
23. Relationship between anti-Müllerian hormone (AMH) and insulin levels during different tanner stages in daughters of women with polycystic ovary syndrome.
Sir-Petermann T; Ladrón de Guevara A; Codner E; Preisler J; Crisosto N; Echiburú B; Maliqueo M; Sánchez F; Perez-Bravo F; Cassorla F
Reprod Sci; 2012 Apr; 19(4):383-90. PubMed ID: 22344736
[TBL] [Abstract][Full Text] [Related]
24. Serum anti-Müllerian hormone concentration in women with polycystic ovary syndrome and type 1 diabetes mellitus.
Łebkowska A; Adamska A; Karczewska-Kupczewska M; Nikołajuk A; Otziomek E; Milewski R; Górska M; Wołczyński S; Kowalska I
Metabolism; 2016 May; 65(5):804-811. PubMed ID: 26961579
[TBL] [Abstract][Full Text] [Related]
25. Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Müllerian hormone cutoff value.
Song DK; Oh JY; Lee H; Sung YA
Korean J Intern Med; 2017 Jul; 32(4):690-698. PubMed ID: 27899014
[TBL] [Abstract][Full Text] [Related]
26. Association of anti-Müllerian hormone and insulin resistance in adolescent girls with polycystic ovary syndrome.
Guo G; Zheng H; Wu X
Endokrynol Pol; 2024; 75(1):83-88. PubMed ID: 38497393
[TBL] [Abstract][Full Text] [Related]
27. Antimüllerian hormone levels and cardiometabolic risk in young women with polycystic ovary syndrome.
Feldman RA; O'Neill K; Butts SF; Dokras A
Fertil Steril; 2017 Jan; 107(1):276-281. PubMed ID: 27842995
[TBL] [Abstract][Full Text] [Related]
28. Anti-Mullerian hormone may be a useful adjunct in the diagnosis of polycystic ovary syndrome in nonobese adolescents.
Sopher AB; Grigoriev G; Laura D; Cameo T; Lerner JP; Chang RJ; McMahon DJ; Oberfield SE
J Pediatr Endocrinol Metab; 2014 Nov; 27(11-12):1175-9. PubMed ID: 25003376
[TBL] [Abstract][Full Text] [Related]
29. Independent association of serum vitamin D with anti-Mullerian hormone levels in women with polycystic ovary syndrome.
Wong HYQ; Li HWR; Lam KSL; Tam S; Shek CC; Lee CYV; Yeung WSB; Ho PC; Ng EHY
Clin Endocrinol (Oxf); 2018 Nov; 89(5):634-641. PubMed ID: 30019416
[TBL] [Abstract][Full Text] [Related]
30. [A pilot study of serum anti-Mullerian hormone in diagnosis of polycystic ovary syndrome based on 2012 Chinese polycystic ovary syndrome diagnosis criteria].
Yang S; Ruan J; Huang W; Tan J; Zhang X; Feng X; Liu D; Fu J; Zhou L; Zhou M
Zhonghua Fu Chan Ke Za Zhi; 2015 Nov; 50(11):819-24. PubMed ID: 26887768
[TBL] [Abstract][Full Text] [Related]
31. Anti-Müllerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study.
Pinola P; Morin-Papunen LC; Bloigu A; Puukka K; Ruokonen A; Järvelin MR; Franks S; Tapanainen JS; Lashen H
Hum Reprod; 2014 Oct; 29(10):2317-25. PubMed ID: 25056088
[TBL] [Abstract][Full Text] [Related]
32. Elevated anti-Mullerian hormone in lean women may not indicate polycystic ovarian syndrome.
Bradbury RA; Lee P; Smith HC
Aust N Z J Obstet Gynaecol; 2017 Oct; 57(5):552-557. PubMed ID: 28597496
[TBL] [Abstract][Full Text] [Related]
33. Polycystic ovary syndrome and anti-Müllerian hormone: role of insulin resistance, androgens, obesity and gonadotrophins.
Cassar S; Teede HJ; Moran LJ; Joham AE; Harrison CL; Strauss BJ; Stepto NK
Clin Endocrinol (Oxf); 2014 Dec; 81(6):899-906. PubMed ID: 25040369
[TBL] [Abstract][Full Text] [Related]
34. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
Sova H; Unkila-Kallio L; Tiitinen A; Hippeläinen M; Perheentupa A; Tinkanen H; Puukka K; Bloigu R; Piltonen T; Tapanainen JS; Morin-Papunen L
Gynecol Endocrinol; 2019 Jul; 35(7):595-600. PubMed ID: 30668196
[TBL] [Abstract][Full Text] [Related]
35. The role of anti-Mullerian hormone and other correlates in patients with polycystic ovary syndrome.
Moursi MO; Salem H; Ibrahim AR; Marzouk S; Al-Meraghi S; Al-Ajmi M; Al-Naimi A; Alansari L
Gynecol Endocrinol; 2023 Aug; 39(1):2247098. PubMed ID: 37573873
[TBL] [Abstract][Full Text] [Related]
36. Is anti-Mullerian hormone an indicator of potential polycystic ovary syndrome in prepubertal girls with simple obesity?
Korkmaz Ö; Gökşen D; Özen S; Darcan Ş
Turk J Pediatr; 2016; 58(4):406-412. PubMed ID: 28276214
[TBL] [Abstract][Full Text] [Related]
37. A prospective study of anti-mullerian hormone and other ovarian and adrenal hormones in adult female acne.
Bansal P; Sardana K; Arora P; Khurana A; Garga UC; Sharma L
Dermatol Ther; 2020 Nov; 33(6):e13974. PubMed ID: 33185003
[TBL] [Abstract][Full Text] [Related]
38. [Value of anti-Müllerian hormone in predicting pregnant outcomes of polycystic ovary syndrome patients undergone assisted reproductive technology].
Li Y; Tan JQ; Mai ZY; Yang DZ
Zhonghua Fu Chan Ke Za Zhi; 2018 Jan; 53(1):23-30. PubMed ID: 29374882
[No Abstract] [Full Text] [Related]
39. [CORRELATION OF ANTI-MULLERIAN HORMONE WITH HORMONAL AND OVARIAN MORPHOLOGICAL CHARACTERISTICS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME WITH AND WITHOUT INSULIN RESISTANCE].
Asanidze E; Khristesashvili J; Pkhaladze L; Barbakadze L
Georgian Med News; 2018 Feb; (Issue):34-40. PubMed ID: 29578420
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of predictive models for polycystic ovary syndrome using serum levels of two antimüllerian hormone isoforms (proAMH and AMH
Pankhurst MW; Shorakae S; Rodgers RJ; Teede HJ; Moran LJ
Fertil Steril; 2017 Nov; 108(5):851-857.e2. PubMed ID: 29079276
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
